Drug

Florida isn't alone in challenging Biden to allow drug imports into Canada

Florida isn’t alone in challenging Biden to allow drug imports into Canada

The Biden administration is facing increasing pressure on some states to let them import drugs from Canada to reduce prescription drug costs. Colorado on Dec. 5 became at least the fourth state to seek federal permission to use the strategy, following Florida, New Hampshire and New Mexico. In August, Florida’s Agency for Health Care Administration …

Florida isn’t alone in challenging Biden to allow drug imports into Canada Read More »

European Commission approves first drug for prurigo nodularis

European Commission approves first drug for prurigo nodularis

tricked®the first and only targeted medicine for prurigo nodularis has been approved by the EC for adults with moderate to severe disease. The European Commission (EC) has extended the marketing authorization for Dupixent® (dupilumab) in the European Union (EU), to treat adults with moderate to severe nodular prurigo (PN) who are candidates for systemic therapy, …

European Commission approves first drug for prurigo nodularis Read More »

'New era of treatment': Israelis among first to receive 'breakthrough' ALS drug

‘New era of treatment’: Israelis among first to receive ‘breakthrough’ ALS drug

Israeli patients have become among the first in the world to start receiving a new ALS drug intended to slow the progression of the degenerative disease. Tofersen, which is injected into the spine as an epidural, gives new hope to two patients at Tel Aviv Sourasky Medical Center. One of them, Narkis Moshe from Nahariya, …

‘New era of treatment’: Israelis among first to receive ‘breakthrough’ ALS drug Read More »

MSU drug developers secure seed funding for cancer and TB drug development

MSU drug developers secure seed funding for cancer and TB drug development

Two Michigan State University biomedical researchers have received a total of $600,000 in high-risk, high-reward Catalyst grants from the Dr. Ralph and Marian Falk Medical Research Trust. Karen Liby, professor in the Department of Pharmacology and Toxicology — a shared department of the Colleges of Osteopathic Medicine and Human Medicine — and Robert Abramovich, associate …

MSU drug developers secure seed funding for cancer and TB drug development Read More »

Pharmaceutical Industry Regenerative Medicine Market Size, Share and Trend Analysis by Region, Drug Class, Route of Administration and Segment Forecast, 2022-2027

Pharmaceutical Industry Regenerative Medicine Market Size, Share and Trend Analysis by Region, Drug Class, Route of Administration and Segment Forecast, 2022-2027

NEW YORK, December 9, 2022 /PRNewswire/ — Pharmaceutical Industry Regenerative Medicine Market Size, Share and Trend Analysis by Region, Drug Class (Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics, Others), Route of Administration (Injectable, Oral, Topical) and Segment Forecast, 2022-2027 Read the full report: https://www.reportlinker.com/p06371494/?utm_source=PRN SummaryPharmacy regenerative medicine market size has been valued at US$29.4 billion in …

Pharmaceutical Industry Regenerative Medicine Market Size, Share and Trend Analysis by Region, Drug Class, Route of Administration and Segment Forecast, 2022-2027 Read More »

Here's When Drug Prices Will Start Falling for Medicare Beneficiaries - Louisiana Illuminator

Here’s When Drug Prices Will Start Falling for Medicare Beneficiaries – Louisiana Illuminator

Starting next month, a $35 cap on insulin prices will go into effect for millions of Medicare beneficiaries. The price cut is one of the first of several policy moves Americans will see in the months and years to come under the Cut Inflation Act signed into law in August. The bill also requires drug …

Here’s When Drug Prices Will Start Falling for Medicare Beneficiaries – Louisiana Illuminator Read More »